Colorectal Cancer

Although testing for microsatellite instability and mismatch repair deficiency has increased for advanced colorectal cancer, substantial gaps in testing remain among certain patient groups, according to study results.

RHB-102 was safe and improved stool consistency in patients with diarrhea-predominant irritable bowel syndrome, or IBS-D, according to a recent study. It was the top story in gastroenterology last week.

A meta-analysis of 31 randomized controlled trials of antihypertensive drugs compared with placebo or other BP-lowering medications found no association between any antihypertensive drugs and cancer outcomes.

Coffee consumption may lower the risk for disease progression and death in patients with advanced or metastatic colorectal cancer, according to recently published study results. It was the top story in hematology/oncology last week.

The Cleveland Clinic appointed Conor Delaney, MD, PhD, as new CEO and president of Cleveland Clinic Florida region.

Healio Gastroenterology presents the following reports on the most recent research in gastrointestinal cancer.

Drinking coffee may reduce the risk for disease progression and death among patients with advanced or metastatic colorectal cancer, according to results of a prospective observational cohort study published in JAMA Oncology.

In this exclusive video, Jennifer Christie, MD, from the Emory School of Medicine, and Douglas K. Rex, MD, from Indiana University School of Medicine, discuss “The Value of Colonoscopy,” a new campaign from the American Society for Gastrointestinal Endoscopy.

The European Society for Medical Oncology announced the recipients of this year’s ESMO Awards.

Delays in colorectal cancer screening due to the cessation of colonoscopies during the COVID-19 pandemic could increase advanced cases and even mortality if the delay stretches beyond 1 year, according to study results.